Polocaine (mepivacaine Hcl) Injection, Solution
Product Images NDC 51662-1535

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Polocaine (mepivacaine Hcl) (NDC 51662-1535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Label (51662 1535 2 Pouch Label)

Label for POLOCAINE (MEPIVACAINE HCl) Injection, 20 mg/mL (2%) solution, 50 mL vial. The label includes the NDC number 51662-1535-2, lot number 123456, and expiration date 2030-01-01. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. Intended for infiltration and nerve block use only.*

FDA Label Image

Box Labeling (51662 1535 3 Box Labeling)

POLOCAINE (MEPIVACAINE HCl) Injection, USP 2%, 1000 mg/50 mL (20 mg/mL) solution in a 50 mL vial. The label includes NDC 51662-1535-3, lot number 123456, and expiration date 2030-01-01. It is manufactured by HF Acquisition Co., LLC, Mukilteo, WA. Storage instructions specify 20° to 25°C (68° to 77°F). This product is for infiltration and nerve block only.*

FDA Label Image

Serialized Labeling (51662 1535 3 Serialized Box Label)

A small white adhesive label with barcode and GS1 barcode data including product identifiers. Text indicates distribution by HF Acquisition Co., LLC, Mukilteo, WA. The label includes numeric codes and a note to see the manufacturer's package insert. "RX ONLY" is printed vertically on the right side. No visible product name, strength, or dosage form on the label itself.*

FDA Label Image

Description (Description)

A table presenting the quantitative composition of POLOCAINE injection solution in various vial sizes and concentrations. It lists amounts (mg/mL) of active ingredient mepivacaine hydrochloride and excipients including sodium chloride, potassium chloride, calcium chloride, methylparaben, and water for injection across 1% to 2% strengths and single or multiple dose vials ranging from 20 mL to 50 mL.*

FDA Label Image

Dosage (Dosage)

A dosage table for POLOCAINE (MEPIVACAINE HCl) injection solution showing concentration, total dose in mL and mg, and specific comments for various procedures including cervical, brachial, pudendal nerve blocks, transvaginal and paracervical blocks, caudal and epidural blocks, infiltration, and therapeutic pain management blocks. The table provides guidance on dose ranges, administration notes, and cautions regarding use of preservative-free vials.*

FDA Label Image

How Supplied (How Supplied)

Data tables listing product codes, units of sale, strengths, and packaging details for POLOCAINE (Mepivacaine HCl Injection, USP) without and with preservatives. The tables specify concentrations of 1%, 1.5%, and 2% in various vial sizes (20 mL, 30 mL, 50 mL) along with associated NDC codes. Storage instructions and manufacturing information by Fresenius Kabi USA are included.*

FDA Label Image

Indications (Indications)

A table presenting concentrations of POLOCAINE (MEPIVACAINE HCl) injection solution used for different anesthesia techniques, including local infiltration (0.5% via dilution or 1%), peripheral nerve blocks (1% and 2%), epidural block (1%, 1.5%, 2%), and caudal block (1%, 1.5%, 2%).*

FDA Label Image

Precautions (Precautions)

A data table listing drug classes in the left column and example drugs in the right column. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with examples such as mepivacaine under Local anesthetics and various other medications under each category.*

FDA Label Image

Structure (Structure)

Chemical structure of mepivacaine hydrochloride, the active ingredient in POLOCAINE (MEPIVACAINE HCl) injection solution. The structure includes a piperidine ring bonded to an amide group and a substituted aromatic ring with two methyl groups, associated with hydrochloride.*

FDA Label Image

Vial (Vial Label)

Label for POLOCAINE (mepivacaine HCl) Injection, USP 2% solution, containing 20 mg/mL of mepivacaine hydrochloride. The label indicates a 50 mL multiple dose vial for infiltration and nerve block only, not intended for spinal anesthesia or dental use. Storage instructions specify 20° to 25°C. The manufacturer is Fresenius Kabi, Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.